Imperva new CEO positive, says Oppenheimer After Imperva named Anthony Bettencourt as itsnew CEO, Oppenheimer believes that Bettencourt's background dovetails with the company's intermediate term and longer term strategy. Oppenheimer reports that the new CEO has a 25 year track record of building and selling fast-growing technology companies. However, it keeps a Perform rating on the name. .
Imperva downgraded to Neutral from Overweight at JPMorgan JPMorgan downgraded Imperva to Neutral citing the recent outperformance of shares. The firm raised its price target for the stock to $45 from $42.